Increase of suicide and accidental death after hematopoietic stem cell transplantation: A cohort study on behalf of the Late Effects Working Party of the European Group for Blood and Marrow Transplantation (EBMT)

Cancer

Volumn 119, Issue 11, 2013, Pages 2012-2021

  Tichelli, André ^a   Labopin, Myriam ^b   Rovõ, Alicia ^a   Badoglio, Manuela ^b   Arat, Mutlu ^c   Van Lint, Maria Teresa ^d   Lawitschka, Anita ^e   Schwarze, Carl Philipp ^f   Passweg, Jakob ^a   Socié, Gérard ^g  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b HÔPITAL SAINT ANTOINE   (France)

^c Florence Nightingale Sisli Hospital   (Turkey)

^d UNIVERSITY OF GENOA   (Italy)

^e ST ANNA CHILDREN S HOSPITAL   (Austria)

^f UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^g SAINT LOUIS HOSPITAL   (France)

Author keywords

accidents; hematopoietic stem cell transplantation; late effects; long term; suicides; survivorship

Indexed keywords

ACCIDENTAL DEATH; ADOLESCENT; ADULT; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CANCER MORTALITY; CASE CONTROL STUDY; CAUSE OF DEATH; CHILD; CHRONIC GRAFT VERSUS HOST DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; EUROPE; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; REGISTER; RELAPSE; RETROSPECTIVE STUDY; RISK FACTOR; SCHOOL CHILD; SUICIDE;

ACCIDENTS; ADOLESCENT; ADULT; AGED; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DISEASE PROGRESSION; EUROPE; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INCIDENCE; INFANT; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; SUICIDE; YOUNG ADULT;

EID: 84878017680     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.27987     Document Type: Article

References (53)

1. Copelan EA,. Hematopoietic stem-cell transplantation. N Engl J Med. 2006; 354: 1813-1826.
2. Gratwohl A, Baldomero H, Aljurf M, et al. Worldwide Network of Blood and Marrow Transplantation. Hematopoietic stem cell transplantation: a global perspective. JAMA. 2010; 303: 1617-1624.
3. Ljungman P, Bregni M, Brune M, et al. European Group for Blood and Marrow Transplantation. Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe 2009. Bone Marrow Transplant. 2010; 45: 219-234.
4. Gooley TA, Chien JW, Pergam SA, et al. Reduced mortality after allogeneic hematopoietic-cell transplantation. N Engl J Med. 2010; 363: 2091-2101.
5. Bhatia S, Robison LL, Francisco L, et al. Late mortality in survivors of autologous hematopoietic-cell transplantation: report from the Bone Marrow Transplant Survivor Study. Blood. 2005; 105: 4215-4222.
6. Bhatia S, Francisco L, Carter A, et al. Late mortality after allogeneic hematopoietic cell transplantation and functional status of long-term survivors: report from the Bone Marrow Transplant Survivor Study. Blood. 2007; 110: 3784-3792.
7. Wingard JR, Majhail NS, Brazauskas R, et al. Long-term survival and late deaths after allogeneic hematopoietic cell transplantation. J Clin Oncol. 2011; 29: 2230-2239.
8. Socie G, Salooja N, Cohen A, et al. Nonmalignant late effects after allogeneic stem cell transplantation. Blood. 2003; 101: 3373-3385.
9. Tichelli A, Rovo A, Passweg J, et al. Late complications after hematopoietic stem cell transplantation. Expert Rev Hematol. 2009; 2: 583-601.
10. Robinson D, Renshaw C, Okello C, Moller H, Davies EA,. Suicide in cancer patients in South East England from 1996 to 2005: a population-based study. Br J Cancer. 2009; 101: 198-201.
11. Robson A, Scrutton F, Wilkinson L, MacLeod F,. The risk of suicide in cancer patients: a review of the literature. Psychooncology. 2010; 19: 1250-1258.
12. Norkin M, Hsu JW, Wingard JR,. Quality of life, social challenges, and psychosocial support for long-term survivors after allogeneic hematopoietic stem-cell transplantation. Semin Hematol. 2012; 49: 104-109.
13. Syrjala KL, Langer SL, Abrams JR, et al. Recovery and long-term function after hematopoietic cell transplantation for leukemia or lymphoma. JAMA. 2004; 291: 2335-2343.
14. Loberiza FR Jr, Rizzo JD, Bredeson CN, et al. Association of depressive syndrome and early deaths among patients after stem-cell transplantation for malignant diseases. J Clin Oncol. 2002; 20: 2118-2126.
15. Andrykowski MA, Brady MJ, Greiner CB, et al. 'Returning to normal' following bone marrow transplantation: outcomes, expectations and informed consent. Bone Marrow Transplant. 1995; 15: 573-581.
16. Andrykowski MA, Bishop MM, Hahn EA, et al. Long-term health-related quality of life, growth, and spiritual well-being after hematopoietic stem-cell transplantation. J Clin Oncol. 2005; 23: 599-608.
17. Wasserman D, Rihmer Z, Rujescu D, et al. The European Psychiatric Association (EPA) guidance on suicide treatment and prevention. Eur Psychiatry. 2012; 27: 129-141.
18. McDowell AK, Lineberry TW, Bostwick JM,. Practical suicide-risk management for the busy primary care physician. Mayo Clin Proc. 2011; 86: 792-800.
19. Syrjala KL, Martin PJ, Lee SJ,. Delivering care to long-term adult survivors of hematopoietic cell transplantation. J Clin Oncol. 2012; 30: 3746-3751.
20. McGwin G, Sims RV, Pulley L, Roseman JM,. Relations among chronic medical conditions, medications, and automobile crashes in the elderly: a population-based case-control study. Am J Epidemiol. 2000; 152: 424-431.
21. Marshall SC,. The role of reduced fitness to drive due to medical impairments in explaining crashes involving older drivers. Traffic Injury Prevention. 2008; 9: 291-298.
22. World Health Organization. International Statistical Classification of Diseases and Related Health Problems, 10th Revision. Geneva, Switzerland: WHO; 2011. http://www.who.int/classifications/icd/en/.
23. Gray RJ,. A class of k-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat. 1988; 16: 1141-1154.
24. European Commission. Eurostat database on public health. Causes of death. Luxembourg: European Commission; 2011. http://epp.eurostat.ec.europa.eu/portal/ page/portal/health/public-health/data-public-health/database.
25. Greydanus D, Patel D, Pratt H,. Suicide risk in adolescents with chronic illness: implications for primary care and specialty pediatric practice: a review. Dev Med Child Neurol. 2010; 52: 1083-1087.
26. Ilgen MA, Zivin K, Austin KL, et al. Severe pain predicts greater likelihood of subsequent suicide. Suicide Life Threat Behav. 2010; 40: 597-608.
27. Kurella M, Kimmel PL, Young BS, Chertow GM,. Suicide in the United States end-stage renal disease program. J Am Soc Nephrol. 2005; 16: 774-781.
28. Gulland A,. One in 10 suicides is among people with a physical illness. BMJ. 2011; 343: d5464.
29. Fang F, Keating NL, Mucci LA, et al. Immediate risk of suicide and cardiovascular death after a prostate cancer diagnosis: cohort study in the United States. J Natl Cancer Inst. 2010; 102: 307-314.
30. Misono S, Weiss NS, Fann JR, Redman M, Yueh B,. Incidence of suicide in persons with cancer. J Clin Oncol. 2008; 26: 4731-4738.
31. Walker J, Hansen CH, Butcher I, et al. Thoughts of death and suicide reported by cancer patients who endorsed the "suicidal thoughts" item of the PHQ-9 during routine screening for depression. Psychosomatics. 2011; 52: 424-427.
32. Fang F, Fall K, Mittleman MA, et al. Suicide and cardiovascular death after a cancer diagnosis. N Engl J Med. 2012; 366: 1310-1318.
33. Ojo AO, Hanson JA, Wolfe RA, Leichtman AB, Agodoa LY, Port FK,. Long-term survival in renal transplant recipients with graft function. Kidney Int. 2000; 57: 307-313.
34. Heinrich TW, Marcangelo M,. Psychiatric issues in solid organ transplantation. Harv Rev Psychiatry. 2009; 17: 398-406.
35. Khera N, Storer B, Flowers ME, et al. Nonmalignant late effects and compromised functional status in survivors of hematopoietic cell transplantation. J Clin Oncol. 2012; 30: 71-77.
36. Flowers ME, Traina F, Storer B, et al. Serious graft-versus-host disease after hematopoietic cell transplantation following nonmyeloablative conditioning. Bone Marrow Transplant. 2004; 35: 277-282.
37. Pidala J, Kurland B, Chai X, et al. Patient-reported quality of life is associated with severity of chronic graft-versus-host disease as measured by NIH criteria: report on baseline data from the Chronic GVHD Consortium. Blood. 2011; 117: 4651-4657.
38. Björkenstam C, Edberg A, Ayoubi S, Rosén M,. Are cancer patients at higher suicide risk than the general population? Scand J Public Health. 2005; 33: 208-214.
39. Yousaf U, Christensen ML, Engholm G, Storm HH,. Suicides among Danish cancer patients 1971-1999. Br J Cancer. 2005; 92: 995-1000.
40. Dormer NR, McCaul KA, Kristjanson LJ,. Risk of suicide in cancer patients in Western Australia, 1981-2002. Med J Aust. 2008; 188: 140-143.
41. Marcelli D, Ingrand P, Delamour M, Ingrand I,. Accidents in a population of 350 adolescents and young adults: circumstances, risk factors and prediction of recurrence [in French]. Bull Acad Natl Med. 2010; 194: 953-964.
42. Somes J, Donatelli NS,. Car versus tree: accident or suicide attempt? J Emerg Nurs. 2011; 37: 179-181.
43. Belkacemi Y, Labopin M, Vernant JP, et al. Cataracts after total body irradiation and bone marrow transplantation in patients with acute leukemia in complete remission: a study of the European Group for Blood and Marrow Transplantation. Int J Radiat Oncol Biol Phys. 1998; 41: 659-668.
44. Tichelli A, Gratwohl A, Egger T, et al. Cataract formation after bone marrow transplantation. Ann Intern Med. 1993; 119: 1175-1180.
45. Tichelli A, Passweg J, Wojcik D, et al. Late cardiovascular events after allogeneic hematopoietic stem cell transplantation: a retrospective multicenter study of the Late Effects Working Party of the European Group for Blood and Marrow Transplantation. Haematologica. 2008; 93: 1203-1210.
46. Schmidt K, Schulz AS, Debatin KM, Friedrich W, Classen CF,. CNS complications in children receiving chemotherapy or hematopoietic stem cell transplantation: retrospective analysis and clinical study of survivors. Pediatr Blood Cancer. 2008; 50: 331-336.
47. Friedman MA, Fernandez M, Wefel JS, Myszka KA, Champlin RE, Meyers CA,. Course of cognitive decline in hematopoietic stem cell transplantation: a within-subjects design. Arch Clin Neuropsychol. 2009; 24: 689-698.
48. Wu LM, Austin J, Hamilton JG, et al. Self-efficacy beliefs mediate the relationship between subjective cognitive functioning and physical and mental well-being after hematopoietic stem cell transplant. Psychooncology. 2012; 21: 1175-1184.
49. Rizzo JD, Curtis RE, Socie G, et al. Solid cancers after allogeneic hematopoietic cell transplantation. Blood. 2009; 113: 1175-1183.
50. Tichelli A, Bucher C, Rovo A, et al. Premature cardiovascular disease after allogeneic hematopoietic stem-cell transplantation. Blood. 2007; 110: 3463-3471.
51. Rovo A, Daikeler T, Halter J, et al. Late altered organ function in very long-term survivors after allogeneic hematopoietic stem cell transplantation: a paired comparison with their HLA-identical sibling donor. Haematologica. 2011; 96: 150-155.
52. Capron DW, Gonzalez A, Parent J, Zvolensky MJ, Schmidt NB,. Suicidality and anxiety sensitivity in adults with HIV. AIDS Patient Care STDS. 2012; 26: 298-303.
53. Juurlink DN, Herrmann N, Szalai JP, Kopp A, Redelmeier DA,. Medical illness and the risk of suicide in the elderly. Arch Intern Med. 2004; 164: 1179-1184.